FDA on PROMs. Two important points
- PMID: 20923843
- DOI: 10.1136/bmj.c5454
FDA on PROMs. Two important points
Comment on
-
FDA guidance on patient reported outcomes.BMJ. 2010 Jun 21;340:c2921. doi: 10.1136/bmj.c2921. BMJ. 2010. PMID: 20566597 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources